多替阿巴拉米片国内上市了没呢？

It has been approved in more than 100 countries and recommended by many authoritative academic institutions in Europe and the United States as a first-line treatment drug for newly treated AIDS patients. Dolutegra is a new drug used to treat AIDS and does not need to consider food effects. For adults and adolescents weighing 40 kg or more, the recommended dose of Dolutegra is one tablet, once daily. Because Dolutegra is a fixed-dose tablet and the dose cannot be reduced, adults or adolescents who weigh less than 40 kg should not be given Dolutegra. Before taking doptabalamid tablets, you need to complete the test to determine whether you carry the special type of "HLA-B*5701" gene. Today we are going to find out whether Duotai abalami tablets are on the market in China?

Dolutegravir is a once-daily three-in-one drug developed by ViiV Healthcare, a joint venture between GlaxoSmithKline and Pfizer. The drug is based on the treatment plan of the integrase inhibitor Tivicay (Dolutegravir) and also contains two nucleoside reverse transcriptase inhibitors, Abacavir and Lamivudine. It was approved by the FDA on August 27, 2014. Subsequently, on January 22, 2018, GlaxoSmithKline (GSK) announced that its single-tablet compound preparation dolutegravir (DTG), a new-generation integrase inhibitor dolutegravir (DTG) as the core, for the treatment of HIV was officially launched in mainland China. This is the first single-pill compound preparation with a complete treatment plan in the field of HIV treatment in mainland China.

The dolutea palamid tablets launched this time are China's first complete single-tablet three-in-one preparation with DTG as the core, filling the gap in single-piece compound preparations. GSK has previously had a DTG drug on the market, with the trade name Tevicay. It was launched in the United States in 2013, but it needs to be used in combination with other drugs. Dolutegra abalami tablets are a complete single-tablet three-in-one preparation with DTG as the core. It can be taken once a day, one tablet at a time, without considering factors such as food, environment, location, etc. AIDS is generally recognized as a chronic disease, and for chronic diseases, patient compliance is particularly important. Doptabalamid tablets, one tablet once a day, reduce the frequency and dosage of medication, and significantly enhance patient compliance.

The above is the content of the listing, I hope it can help you!